Are you active in the field of organ-on-a-chip (OoC) technology and organoids? Are you curious about developments in Boston - the heart of the world's most innovative biotech hub – and the federal research and regulatory ecosystem in Washington, D.C.? Then join this innovation mission.
Venue: Boston,US
Attendee information:
- Participation costs €350 per person, excluding VAT, travel and accommodation costs, and individual expenses.
- Please register by 29 May 2026.
Organiser:
Netherlands Enterprise Agency
For whom?
This mission is intended for:
- entrepreneurs;
- researchers;
- engineers;
- clinicians;
- ethicists;
- business developers; and
- anyone affiliated with: a knowledge institution;
- an academic hospital;
- a technology company;
- a patient organisation.
Do you fall within this target group and are you active in the field of organ-on-chip (OoC) technologies and organoids? Are you interested in transatlantic connections to further develop your research/solutions? Then this innovation mission is of interest to you.
This innovation mission is your opportunity to gain insight into the rapid developments and investments in OoC technologies in Boston and Washington D.C.. This is a fast-growing industry that is transforming drug development, disease modelling and personalised medicine.
Why Boston?
Boston, Massachusetts, is a global leader in life sciences and the health sector. From research and development to entrepreneurship and commercialisation, Boston is at the forefront of biotechnology. This is largely thanks to the supportive ecosystem of government, businesses, universities, venture capital and entrepreneurs.
Furthermore, the partnership between Massachusetts and the Netherlands is unique. With both a Memorandum of Understanding (MoU) and a cooperation programme in the field of Life Sciences & Health, there is no other formal agreement between the Massachusetts government and any other country that is comparable.
The core of this partnership is improving the lives of patients. This partnership remains relevant and successful thanks to the commitment of both parties to this transatlantic collaboration.
Why Washington. D.C.?
Washington, D.C. is the center of all U.S. biomedical research policy, funding, and strategy. It is home to the National Institutes of Health (NIH), the primary federal agency for conducting and supporting medical research. Through its institutes and centers, the NIH plays a decisive role in shaping national and global research agendas and accelerating breakthroughs that improve health and reduce disease.
This includes the NIH Standardized Organoid Modeling (SOM) Center, which develops reproducible organoid models to accelerate translational research. By advancing standardized human tissue models, the SOM Center directly complements organ-on-a-chip technologies, creating a bridge between cutting-edge bioengineering and federally guided disease modeling.
Engagement with the federal research ecosystem provides direct access to key decision-makers, funding bodies, and national initiatives. Just as Boston connects innovators with industry, Washington, D.C. aligns researchers with federal priorities and long-term support - forming a powerful foundation for sustainable US-NL collaboration in organ-on-a-chip and organoid technologies.
What can you expect?
This mission brings together experts from both the Dutch and American ecosystems to:
- connect;
- explore research and development opportunities;
- collaborate on the further development of OoC technologies.
Together, we want to build a new industrial sector focused on improving patient outcomes. Participating in this mission will give you insights into the opportunities for transatlantic collaboration.
More information about the programme, costs and where to register, can be found here.
Source: RVO